Z-1189-2017 Class II Terminated

Recalled by Becton Dickinson & Company — Franklin Lakes, NJ

FDA device recall Z-1189-2017 was initiated by Becton Dickinson & Company on Jan 16, 2017 and is designated Class II. Reason for recall: A portion of this lot of blood collection tubes was manufactured with approximately twice the expected amount of buffered sodium citrate additive, an anticoagulant. The recall status is terminated (terminated Feb 7, 2018). Affected quantity: 1,488,800 tubes.

Recall details

Product Type
Devices
Report Date
Feb 22, 2017
Initiation Date
Jan 16, 2017
Termination Date
Feb 7, 2018
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
1,488,800 tubes

Product description

BD Vacutainer Buffered Sodium Citrate: (9NC) Blood Collection Tube (4.5 ml x 13 x 75 mm) Catalog Number: 369714 Product Usage: The BD Vacutainer Safety Coagulation tube is an evacuated blood collection tube that provides means of collecting, transporting and processing blood in a closed tube. The buffered sodium citrate additive provides an anti-coagulated specimen that may be used for clinical laboratory coagulation assays and determinations

Reason for recall

A portion of this lot of blood collection tubes was manufactured with approximately twice the expected amount of buffered sodium citrate additive, an anticoagulant.

Distribution pattern

Worldwide Distribution - US Nationwide and the countries of Canada, Mexico, Indonesia

Code information

Lot 6090572

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-1189-2017
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-1189-2017. Report a data issue: hello@regdatalab.com.